Copenhagen, Denmark and Solbiate Olana, Italy – 25.11.2025 – RetinaLyze System A/S is pleased to announce a new strategic partnership with FE-Group srl, one of Italy’s well-established providers of ophthalmic and optometric technologies.
This collaboration brings RetinaLyze’s CE-certified AI screening software to eye-care professionals across Italy supporting earlier detection, more consistent clinical decisions, and improved patient pathways.
Scalable, reliable diagnostic support tools
Italy’s eye-care market is experiencing strong demand for scalable, reliable diagnostic support tools. Optometrists and ophthalmologists are increasingly looking for solutions that help them:
Detect diabetic retinopathy, AMD, glaucoma and other pathologies earlier
Standardize clinical decision-making across teams and locations
Manage higher patient volumes without sacrificing quality
Introduce telemedicine workflows and remote screening models
Strengthen preventative eye care with fast, reproducible results
By joining forces with FE-Group srl, RetinaLyze is now positioned to meet these needs with local presence, expertise, and distribution.
Decades of experience
FE-Group srl has decades of experience in the ophthalmic equipment market and a strong reputation for working closely with clinics, optometry practices, and medical centers throughout Italy. Their portfolio spans diagnostic imaging, refraction technologies, and integrated workflow tools making RetinaLyze a natural fit.
With their established network and technical know-how, FE-Group srl will support Italian customers with local sales and onboarding, product education and demonstrations, workflow integration guidance and ongoing customer support.
This ensures Italian clinicians get both advanced technology and hands-on, local service.
Strengthening preventive eye care in Italy
The introduction of RetinaLyze into the FE-Group portfolio enhances the availability of modern AI-supported screening. Eye-care providers can now seamlessly add:
Fundus image analysis with instant pathology indicators
OCT analysis modules for structural assessments
Automated diabetic eye screening workflows
Decision-support tools that improve consistency and reduce oversight risk
Together, this helps practices deliver more timely interventions and reduce preventable vision loss.
Looking ahead
RetinaLyze and FE-Group srl share a clear ambition: to make high-quality preventive eye care accessible throughout Italy. This partnership is a key step toward that vision, combining world-class screening technology with trusted local distribution.
About RetinaLyze System A/S
RetinaLyze System A/S is a Denmark-based software company that provides artificial intelligence and telemedicine solutions for the optometry and healthcare industry. Its innovative software platform is designed to assist healthcare professionals in the early detection of eye diseases, enhancing patient outcomes through timely intervention.
About FE-Group srl
FE-Group is the Italian and international point of reference for purchasing products, instrumentation and complete systems for optical and ophthalmic specialists. Along with the best technology and quality you can count on a single point of contact for each project/supply, continuous assistance and training.
For more information about FE-Group srl, visit:
www.fe-group.it